Ocuphire Pharma (OCUP.Q), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for treatment of several eye disorders, announced today that its VEGA-1 Phase 2 clinical trial…
Latest News
Purebread Brands (BRED.V): The best thing since sliced bread got crap
Voyageur Pharmaceuticals (VM) took a mine and turned it into a pharma company
Can your phone confirm you have strep throat? Light AI (ALGO.E) says yes
Prospera Energy (PEI.V)’s big corporate evolution: From incompetence to dishonesty
Brera Holdings (BREA.Q) pioneering pubco sports investment model, but is it a win?
“The markets are dead!”: Emerita Resources (EMO.V) shows otherwise with massive upside coming